Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment by Robinson, PC, Richards, D, Tanner, HL, Feldmann, M

The potential for repurposing anti-TNF as a therapy for the treatment of COVID-19 by Robinson, PC, Liew, DFL, Liew, JW, Monaco, C, Richards, D, Shivakumar, S, Tanner, HL, Feldmann, M

COVID-19 therapeutics: challenges and directions for the future by Robinson, PC, Liew, DFL, Tanner, HL, Grainger, JR, Dwek, RA, Reisler, RB, Steinman, L, Feldmann, M, Ho, L-P, Hussell, T, Moss, P, Richards, D, Zitzmann, N